Effects of ibuprofen on the physiology and outcome of rabbit endotoxic shock

BMC Infectious Diseases

Volumn 2, Issue , 2002, Pages

  Celik, Ilhami ^a   Akbulut, Ayhan ^a   Kilic, S Sirri ^a   Rahman, Ali ^a   Vural, Pervin ^b   Canbaz, Mukaddes ^b   Felek, Suleyman ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IBUPROFEN; PROSTAGLANDIN E2; THROMBOXANE B2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; BODY TEMPERATURE; BREATHING RATE; CONTROLLED STUDY; DRUG MECHANISM; HEART RATE; HEMATOCRIT; LEUKOCYTE COUNT; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; RECTUM TEMPERATURE; SEPTIC SHOCK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME; URINALYSIS; ANIMAL; BLOOD PRESSURE; BREATHING; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION; URINE;

ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HEART RATE; HEMATOCRIT; IBUPROFEN; LEUKOCYTE COUNT; PLATELET COUNT; RABBITS; RANDOM ALLOCATION; RESPIRATION; SHOCK, SEPTIC; THROMBOXANE B2;

EID: 2942625716     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-2-26     Document Type: Article

References (33)

1. Hubbard JD, Janssen HF: Increased microvascular permeability in canine endotoxic shock: protective effects of ibuprofen. Circ Shock 1988, 26(2):169-83
2. Karima R, Matsumoto S, Higashi H: The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999, 5(3):123-32
3. Fletcher JR: The effects of ibuprofen on eicosanoid synthesis in sepsis. Crit Care Med 1999, 27(4):669-70
4. Griffin MP, Gore DC, Lobe TE, Flynn JF, Traber DL, Herndon DN: Ibuprofen therapy in experimental porcine gram-negative septic shock. Resuscitation 1991, 22(1):75-83
5. Jacobs ER, Soulsby ME, Bone RC, Wilson FJ, Hiller FC: Ibuprofen in canine endotoxic shock. J Clin Invest 1982, 70(3):536-41
6. Fink MP, MacVittie TJ, Casey LC: Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg 1984, 200(5):619-26
7. Hulton NR, Johnson DJ, Willmore DW: Limited effects of prostaglandin inhibitors in Escherichia coli sepsis. Surg 1985, 98(2):291-7
8. Coran AG, Drongowski RA, Paik JJ, Remick DG: Ibuprofen intervention in canine septic shock: reduction of pathophysiology without decreased cytokines. J Surg Res 1992, 53(3):272-9
9. Herbertson M, Werner H, Studer W, Russell JA, Walley KR: Decreased left ventricular contractility during porcine endotoxemia is not prevented by ibuprofen. Crit Care Med 1996, 24(5):815-9
10. Bernard GR, Wheeler AP, Russell JA, et al: The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997, 336(13):912-8
11. Northover BJ, Subramanian G: Analgesics-antipyretics drugs as antagonists of endotoxic shock in dogs. J Pathol Bacteriol 1962, 83:463-8
12. Rockwell WB, Ehrlich : Ibuprofen in acute-care therapy. Ann Surg 1990, 211(1):78-83
13. Kopolovic R, Thrailkill KM, Martin DT, Ambrose T, Vento M, Carey LC, Cloutier CT: Effects of ibuprofen on a porcine model of acute respiratory failure. J Surg Res 1984, 36(4):300-5
14. Balk RA, Jacobs RF, Tryka F, Townsed JW, Walls RC, Bone RC: Effects of ibuprofen on neutrophil function and acute lung injury in canine endotoxic shock. Crit Care Med 1988, 16(11):1121-7
15. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321(5):280-7
16. 2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis 1991, 144(5):1095-1101
17. Martich GD, Parker MM, Cunnion RE, Suffredini AF: Effects of ibuprofen and pentoxiphylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol 1992, 73(3):925-31
18. Revhaug A, Michie HR, Manson JM, Watters JM, Dinarello CA, Wolf SM, Willmore DW: Inhibition of cyclo-oxygenase attenuates the metabolic response to the endotoxin in humans. Arch Surg 1988, 123(2):162-170
19. Yamanaka S, Iwao H, Yukimura T, Kim S, Miura K: Effect of the thrombocyte-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the hemodynamic changes in canine experimental endotoxic shock. Br J Pharmacol 1993, 110(4):1501-7
20. Beck RR, Abel FL: Effect of ibuprofen on the course of canine endotoxin shock. Circ Shock 1987, 23(1):59-70
21. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D: Immunopathologic alterations in murine models of sepsis of increasing severity. Infection and Immunity 1999, 66(12):6603-10
22. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB: Effect of ibuprofen in patients with severe sepsis: a randomized, double-blinded, multicenter study. The Ibuprofen Study Group. Crit Care Med 1991, 19(11):1339-47
23. Arons MM, Wheeler AP, Bernard GR, et al: Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 1999, 27(4):699-707
24. Mullen PG, Windsor AC, Walsh CJ, et al: Combined ibuprofen and monoclonal antibody to tumor necrosis factor-alpha attenuate hemodynamic dysfunction and sepsis-induced acute lung injury. J Trauma 1993, 34(5):612-21
25. Bjornson AB, Knippenberg RW, Bjornson HS: Nonsteroidal anti-inflammatory drugs correct the bactericidal defect of polymorphonuclear leukocytes in a guinea pig model of thermal injury. J Infect Dis 1988, 157(5):959-67
26. Baumgartner JD, Calandra T: Treatment of sepsis: Update on causes and complications. J Crit Ilness 1999, 7:1233-54
27. Adams T, Traber DL: The effects of a prostaglandin synthetase inhibitor, ibuprofen, on the cardiopulmonary response to endotoxin in sheep. Circ Shock 1982, 9(5):481-9
28. Fletcher JR, Collins JN, Graves ED, Luterman A, Williams MD, Izenberg SD: Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann Surg 1993, 217(6):668-75
29. Wise WC, Halushka PV, Knapp RG, Cook JA: Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock. Circ Shock 1985, 17(1):59-71
30. Rosello AM, Ferron-Orihuela JA, Ruiz-Cabello F, Garrote-Lara D, Fernandez-Mondeyar E, Delgado-Carrasco ML: Differential effects of IL-1β and ibuprofen after endotoxic challenge in mice. J Surg Research 1997, 67(2):199-204
31. Vural P, Canbaz M, Akbulut A, Celik I: Effects of ibuprofen on plasma endothelin levels and some vital parameters during endotoxin shock in rabbits. Clin Chim Acta 2002, 316(1-2):101-8
32. Schirmer WJ, Schirmer JM, Townsed MC, Fry DE: Effects of ibuprofen, indomethacin, and imidazole on survival in sepsis. Curr Surg 1987, 44(2):102-5
33. Young JS, Passmore JC: Haemodynamic and renal advantages of dual cyclooxygenase and leukotriene blockade during canine endotoxic shock. Circ Shock 1990, 32(3):243-55